Pharmacokinetics, distribution and anti-tumor efficacy of liposomal mitoxantrone modified with a luteinizing hormone-releasing hormone receptor-specific peptide

Linhua Zhang1 Key Laboratory of Biomedical Material of Tianjin, Institute of Biomedical Engineering, Peking Union Medical College and Chinese Academy of Medical Sciences, Tianjin, China

Yanqing Ren2 Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease, Pharmaceutical College, Hebei University of Chinese Medicine, Shijiazhuang City, Hebei Province, China

Yong Wang3 Department of Physics and Chemistry, College of Medicine, Hebei University, Baoding City, Hebei Province, China

Yingna He2 Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease, Pharmaceutical College, Hebei University of Chinese Medicine, Shijiazhuang City, Hebei Province, ChinaCorrespondence[email protected] [email protected]

Wei Feng2 Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease, Pharmaceutical College, Hebei University of Chinese Medicine, Shijiazhuang City, Hebei Province, ChinaCorrespondence[email protected] [email protected]

Cunxian Song1 Key Laboratory of Biomedical Material of Tianjin, Institute of Biomedical Engineering, Peking Union Medical College and Chinese Academy of Medical Sciences, Tianjin, China

Pages 1097-1105 | Published online: 26 Feb 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

PetersCBrownSAntibody-drug conjugates as novel anti-cancer chemotherapeuticsBiosci Rep2015354ii
Google Scholar
GrahamSMCarlisleRChoiJJInertial cavitation to non-invasively trigger and monitor intratumoral release of drug from intravenously delivered liposomesJ Control Release201417810110724368302
PubMed Web of Science ®Google Scholar
Pérez-HerreroEFernández-MedardeAAdvanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapyEur J Pharm Biopharm201593527925813885
PubMed Web of Science ®Google Scholar
Zununi VahedSSalehiRDavaranSSharifiSLiposome-based drug co-delivery systems in cancer cellsMater Sci Eng C Mater Biol Appl2017711327134127987688
PubMed Web of Science ®Google Scholar
LiJGuoCFengFCo-delivery of docetaxel and palmitoyl ascorbate by liposome for enhanced synergistic antitumor efficacySci Rep201663878727934917
PubMed Web of Science ®Google Scholar
TorchilinVPRecent advances with liposomes as pharmaceutical carriersNat Rev Drug Discov20054214516015688077
PubMed Web of Science ®Google Scholar
DrummondDCNobleCOHayesMEParkJWKirpotinDBPhar-macokinetics and in vivo drug release rates in liposomal nanocarrier developmentJ Pharm Sci200897114696474018351638
PubMed Web of Science ®Google Scholar
YanZYangYWeiXTumor-penetrating peptide mediation: an effective strategy for improving the transport of liposomes in tumor tissueMol Pharm201411121822524325555
PubMedGoogle Scholar
JakobyJBeuschleinFMentzSHantelCSüssRLiposomal doxoru-bicin for active targeting: surface modification of the nanocarrier evaluated in vitro and in vivo: challenges and prospectsOncotarget2015641436984371126497207
PubMedGoogle Scholar
Cordeiro PedrosaLRvan TellingenOSoulliéTPlasma membrane targeting by short chain sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma xenograft modelEur J Pharm Biopharm20159420721925982691
PubMed Web of Science ®Google Scholar
Abu LilaASIshidaTLiposomal delivery systems: Design optimization and current applicationsBiol Pharm Bull201740111028049940
PubMed Web of Science ®Google Scholar
GhanghoriaRKesharwaniPTekadeRKJainNKTargeting luteinizing hormone-releasing hormone: A potential therapeutics to treat gyne-cological and other cancersJ Control Release201826927730127840168
PubMed Web of Science ®Google Scholar
ZhuSWangQJiangJLuoYSunZA conjugate of methotrexate and an analog of luteinizing hormone releasing hormone shows increased efficacy against prostate cancerSci Rep201663389427654169
PubMed Web of Science ®Google Scholar
EngelJBSchallyAVBuchholzSSeitzSEmonsGOrtmannOTargeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH)Arch Gynecol Obstet2012286243744222555802
PubMed Web of Science ®Google Scholar
HuTCaoHYangCLHD-modified mechanism-based liposome coencapsulation of mitoxantrone and prednisolone using novel lipid bilayer fusion for tissue-specific colocalization and synergistic antitu-mor effectsACS Appl Mater Interfaces20168106586660126907854
PubMed Web of Science ®Google Scholar
LingGZhangTZhangPSunJHeZNanostructured lipid-carrageenan hybrid carriers (NLCCs) for controlled delivery of mitoxantrone hydrochloride to enhance anticancer activity bypassing the BCRP-mediated effluxDrug Dev Ind Pharm20164281351135926754913
PubMed Web of Science ®Google Scholar
HeYZhangLSongCLuteinizing hormone-releasing hormone receptor-mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomesInt J Nanomedicine2010569770520957221
PubMed Web of Science ®Google Scholar
HeYZhangLZhuDSongCDesign of multifunctional magnetic iron oxide nanoparticles/mitoxantrone-loaded liposomes for both magnetic resonance imaging and targeted cancer therapyInt J Nanomedicine201494055406625187709
PubMed Web of Science ®Google Scholar
ArakiTKonoYOgawaraKFormulation and evaluation of paclitaxel-loaded polymeric nanoparticles composed of polyethylene glycol and polylactic acid block copolymerBiol Pharm Bull20123581306131322863930
PubMed Web of Science ®Google Scholar
HuangWZhangJDornHCZhangCAssembly of bio-nanoparticles for double controlled drug releasePLoS One201389e7467924040316
PubMed Web of Science ®Google Scholar
HouLFengQWangYMultifunctional hyaluronic acid modified graphene oxide loaded with mitoxantrone for overcoming drug resistance in cancerNanotechnology201627101570126595807
PubMed Web of Science ®Google Scholar
LingGZhangTZhangPSunJHeZSynergistic and complete reversal of the multidrug resistance of mitoxantrone hydrochloride by three-in-one multifunctional lipid-sodium glycocholate nanocarriers based on simultaneous BCRP and Bcl-2 inhibitionInt J Nanomedicine2016114077409127601896
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Pharmacokinetics, distribution and anti-tumor efficacy of liposomal mitoxantrone modified with a luteinizing hormone-releasing hormone receptor-specific peptide

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Pharmacokinetics, distribution and anti-tumor efficacy of liposomal mitoxantrone modified with a luteinizing hormone-releasing hormone receptor-specific peptide

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date